Aignostics
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, is pioneering computational pathology for pharmaceutical research and diagnostics. Its proprietary "Explainable AI" platform draws on research from Fraunhofer Society, Charité, and TU Berlin to overcome the typical "black-box" problem of AI in pathology. Aignostics' focus lies on developing bespoke AI models for clinical trials and CDx development.
Press releases
Press
Aignostics Raises €14m Series A to Advance AI-powered Pathology
Oversubscribed financing round with top-tier life science investors, led by Wellington PartnersSpin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseasesFunds to expand US market presence and further advance AI platform
Berlin, Germany, 15th September 2022 – Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “
Press
Aignostics raises €5m Seed Round to advance AI-powered pathology
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, pioneering computational pathology for pharmaceutical research and diagnostics, has announced today the closing of €5m in seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the round, with participation from the High-Tech Gründerfonds (HTGF), VC Fonds Technologie der IBB Beteiligungsgesellschaft, and Future Capital.
Aignostics formally started out in early 2018, when r
Info & Contact
- E–Mail:
- info@aignostics.com
Address
Aignostics GmbH
Schumannstraße 17
10117 Berlin
Schumannstraße 17
10117 Berlin
In portfolio
24. Aug 2020